Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials
Jihoon Lim, Imen Farhat, Antonios Douros, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0266142-e0266142
Open Access | Times Cited: 25

Showing 25 citing articles:

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder
Christian Heidbreder, Paul J. Fudala, Mark K. Greenwald
Drug and Alcohol Dependence Reports (2023) Vol. 6, pp. 100133-100133
Open Access | Times Cited: 30
Pharmacological treatment for substance use disorder: A systematic review
Joaquín Mateu-Mollá, Bartolomé Pérez Gálvez, Víctor José Villanueva‐Blasco
Addictive Behaviors (2025) Vol. 163, pp. 108242-108242
Closed Access
A randomized controlled trial of effectiveness of brief structured family intervention for patients with opioid dependence and their family members
Yesh Chandra Singh, Siddharth Sarkar, Gauri Shanker Kaloiya, et al.
Drug and Alcohol Dependence (2025) Vol. 269, pp. 112602-112602
Closed Access
Non-communicable diseases in Eritrea: a review of challenges, risk factors and public health strategies
Abdulkadir Abdu, Hossamaldeen Bakrey, Mohamedidris Hamed, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
The Neuroscience of Addiction
Toheeb O. Oyerinde, Abraham Olufemi Asuku, Tobiloba Samuel Olajide, et al.
Advances in medical education, research, and ethics (AMERE) book series (2025), pp. 289-322
Closed Access
Emergency Medical Services Utilization of Medication for Opioid Use Disorder: A Narrative Review of the Literature and Analysis of Prehospital Buprenorphine Protocols
Kasha Bornstein, David Rayburn
Prehospital Emergency Care (2025), pp. 1-20
Closed Access
Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials
Heidar Sharafi, Hamzah Bakouni, Christina McAnulty, et al.
Addiction (2023) Vol. 119, Iss. 2, pp. 211-224
Open Access | Times Cited: 12
Self-Adjuvanting TLR7/8 Agonist and Fentanyl Hapten Co-Conjugate Achieves Enhanced Protection against Fentanyl Challenge
N.R. Powers, Casey J. Massena, Bethany Crouse, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 10, pp. 1811-1821
Open Access | Times Cited: 10
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the OPTIMA study
Hamzah Bakouni, Christina McAnulty, Ovidiu Tatar, et al.
American Journal on Addictions (2023) Vol. 32, Iss. 5, pp. 469-478
Open Access | Times Cited: 9
Risk of drug-related death associated with co-prescribing of gabapentinoids and Z-drugs among people receiving opioid-agonist treatment: a national retrospective cohort study
Megan Glancy, Norah Palmateer, Alan C. Yeung, et al.
Psychiatry Research (2024) Vol. 339, pp. 116028-116028
Open Access | Times Cited: 2
Management of opioid use disorder: 2024 update to the national clinical practice guideline
Igor Yakovenko, Yvette Mukaneza, Katuschia Germé, et al.
Canadian Medical Association Journal (2024) Vol. 196, Iss. 38, pp. E1280-E1290
Open Access | Times Cited: 2
The role of attachment and personality traits in choosing opiate addiction replacement therapy
Alena Gizdić, Vesna Antičević, Igna Brajević-Gizdić
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Associations Between Opioid Agonist Treatment and Withdrawal Symptoms: Exploratory Analyses from the OPTIMA Study
Hamzah Bakouni, Laurent Elkrief, Sabrina Bijou-Coulon, et al.
The Canadian Journal of Addiction (2024) Vol. 15, Iss. 1, pp. 6-15
Open Access | Times Cited: 1
Use of psychoactive substances in the regional methadone center in Serbia
Tamara Popović, Aleksandra Dickov, Vladimir Knežević, et al.
Zdravstvena zastita (2024) Vol. 53, Iss. 2, pp. 18-33
Open Access | Times Cited: 1
Stigma and level of familiarity with opioid maintenance treatment (OMT) among specialist physicians in Israel
Rozner Lihi, Delayahu Yael, Silviu Brill, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Flexible Buprenorphine/Naloxone Treatment Models: Safe and Effective in Reducing Opioid Use Among Persons With Prescription Opioid Use Disorder
Elizabeth C. Saunders
American Journal of Psychiatry (2022) Vol. 179, Iss. 10, pp. 699-701
Open Access | Times Cited: 4
Dental Disorders Reported to the FDA Adverse Event Reporting System in Association with Buprenorphine: An Analysis by Ingredient Composition and Route of Administration
Richard H. Woods
Current Drug Safety (2023) Vol. 19, Iss. 2, pp. 261-267
Closed Access | Times Cited: 2
Willingness to utilize a mobile treatment unit in five counties at the epicenter of the US rural opioid epidemic
Snigdha Peddireddy, Melvin D. Livingston, April M. Young, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 159, pp. 209262-209262
Closed Access | Times Cited: 2
The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis
Moein Zangiabadian, Saeid Golmohammadi, Seyed Aria Nejadghaderi, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 4
Pilot Testing an Asynchronous Online Harm Reduction and Pharmacotherapy Stigma Reduction Training for Substance Use Treatment Professionals
Sandra H. Sulzer, Suzanne Prevedel, Tyson S. Barrett, et al.
Journal of Drug Issues (2024)
Closed Access
The Nexus of Aging and Substance Use: A Scoping Review of Therapeutic Modalities for Geriatric Substance Use Disorders
Noah Leton
Cureus (2024)
Open Access
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder
Alessandro Serretti
International Clinical Psychopharmacology (2024) Vol. 39, Iss. 6, pp. 339-340
Closed Access
Opioide
Marc Walter, Michael Soyka
Elsevier eBooks (2024), pp. 209-233
Closed Access
Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic
Teresa López‐Castro, Andrea Jakubowski, Mariya Masyukova, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 157, pp. 209235-209235
Open Access | Times Cited: 1
No obvious effect on mortality from a patient choice reform expanding access to opioid disorder treatment – results from a natural experiment of policy change in Sweden
Anders Håkansson, Sahar Janfada-Baloo, Jonas Berge
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access
Page 1

Scroll to top